[Myotonolysis by means of orphenadrine citrate. Clinical and electromyographic studies in cerebral and spinal spasticity].
D000200:Action Potentials; D001332:Automatism; D002493:Central Nervous System Diseases / Q000188:drug therapy*; D002951:Citrates; D004576:Electromyography; D006801:Humans; D009128:Muscle Spasticity / Q000188:drug therapy*; D009966:Orphenadrine / Q000494:pharmacology / Q000627:therapeutic use*; D012018:Reflex; D012021:Reflex, Abnormal; D013035:Spasm / Q000188:drug therapy*
D002951:Citrates; D009966:Orphenadrine
Myotonolyse durch Orphenadrincitrat. Klinische und elektromyographische Untersuchungen bei cerebraler und spinaler Spastik.